The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Advances in the development and application of microbial consortia for metabolic engineering
Open accessAbstract
Recent advances in metabolic engineering enable the production of high-value chemicals via expressing complex biosynthetic pathways in a single microbial host. However, many engineered strains suffer from poor product yields due to redox imbalance and excess metabolic burden, and require compartmentalization of the pathway for optimal function. To address this problem, significant developments have been made towards co-cultivation of more than one engineered microbial strains to distribute metabolic burden between the co-cultivation partners and improve the product yield. In this emerging approach, metabolic pathway modules can be optimized separately in suitable hosts that will then be combined to enable optimal functionality of the complete pathway. This modular approach broadens the possibilities to fine tune sophisticated production platforms and thus achieve the biosynthesis of very complex compounds. Here, we review the different applications and the overall potential of natural and artificial co-cultivation systems in metabolic engineering in order to improve bioproduction/bioconversion. In addition to the several advantages over monocultures, major challenges and opportunities associated with co-cultivation are also discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849 · cited 1×
“They allow high-throughput screening and in-depth monitoring of drug effects on cell–cell interactions (Fang and Eglen, 2017; Goers et al., 2014).”
BackgroundMixed Culture Biotechnology for Bioenergy Production
Kleerebezem, R., & van Loosdrecht, M. C. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.05.001 · Cited by 624
Cited by
Construction of microbial consortia for microbial degradation of complex compounds
Cao, Z., Yan, W., Ding, M., & Yuan, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1051233 · Cited by 274
Organic acids as antimicrobial food agents: applications and microbial productions
Coban, H. B. (2020) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-019-02256-w · Cited by 268
Intasian, P., Prakinee, K., Phintha, A., Trisrivirat, D., Weeranoppanant, N., Wongnate, T., & Chaiyen, P. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00121 · Cited by 256
Biotechnological basis of microbial consortia for the removal of pesticides from the environment
Bhatt, P., Bhatt, K., Sharma, A., Zhang, W., Mishra, S., & Chen, S. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1853032 · Cited by 248
Rosero-Chasoy, G., Rodríguez-Jasso, R. M., Aguilar, C. N., Buitrón, G., Chairez, I., & Ruiz, H. A. (2021) · Bioresource Technology · doi:10.1016/j.biortech.2020.124458 · Cited by 111
Metadata
- Authors
- Jawed, K., Yazdani, S. S., & Koffas, M. A.
- Venue
- Metabolic Engineering Communications
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 9
- Pages
- e00095
- ISSN
- 2214-0301 (ISSN-L)
- OpenAlex
- W2946268652
- Cited by
- 165
- References
- 2
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advances in the development and application of microbial consortia for metabolic engineering. https://app.cochat.ai/papers/10.1016/j.mec.2019.e00095
- The paper
- Jawed, K., Yazdani, S. S., & Koffas, M. A. (2019). Advances in the development and application of microbial consortia for metabolic engineering. Metabolic Engineering Communications. https://doi.org/10.1016/j.mec.2019.e00095
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.